These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29709968)

  • 1. A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2.
    Omura N; Yoshikawa T; Fujii H; Shibamura M; Inagaki T; Kato H; Egawa K; Harada S; Yamada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 May; 71(3):229-233. PubMed ID: 29709968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live vaccinia virus recombinants expressing herpes simplex virus genes.
    Rooney JF; Wohlenberg CR; Moss B; Notkins AL
    Rev Infect Dis; 1991; 13 Suppl 11():S898-903. PubMed ID: 1664124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of recombinant vaccinia virus expressing HSV-2 gD gene as live recombinant vaccine strain].
    Yan H; Rong M; Ruan L; Hou Y; He N; Zhu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):16-20. PubMed ID: 15619895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
    Baghian A; Chouljenko VN; D'Auvergne O; Newman MJ; Baghian S; Kousoulas KG
    J Med Microbiol; 2002 Apr; 51(4):350-357. PubMed ID: 11926742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.
    Cantin EM; Eberle R; Baldick JL; Moss B; Willey DE; Notkins AL; Openshaw H
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5908-12. PubMed ID: 3303033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC; Schwartz JA; Andersen H; Eldridge JH; Xu R; Ota-Setlik A; Geltz JJ; Halford WP; Fouts TR
    Viral Immunol; 2017 Apr; 30(3):178-195. PubMed ID: 28085634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome.
    Yoshikawa T; Taniguchi S; Kato H; Iwata-Yoshikawa N; Tani H; Kurosu T; Fujii H; Omura N; Shibamura M; Watanabe S; Egawa K; Inagaki T; Sugimoto S; Phanthanawiboon S; Harada S; Yamada S; Fukushi S; Morikawa S; Nagata N; Shimojima M; Saijo M
    PLoS Pathog; 2021 Feb; 17(2):e1008859. PubMed ID: 33534867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
    Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
    Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI
    J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.
    Manservigi R; Boero A; Argnani R; Caselli E; Zucchini S; Miriagou V; Mavromara P; Cilli M; Grossi MP; Balboni PG; Cassai E
    Vaccine; 2005 Jan; 23(7):865-72. PubMed ID: 15603886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.
    Burn C; Ramsey N; Garforth SJ; Almo S; Jacobs WR; Herold BC
    J Infect Dis; 2018 Feb; 217(5):754-758. PubMed ID: 29216362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel High-Intensity Focused Ultrasound-Treated Herpes Simplex Virus 2 Vaccine Induces Long-Term Protective Immunity against Lethal Challenge in Mice.
    Xiao J; Zhou X; Luo Y; Wang S; Yang Z; Yi Y; Xiong H
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adenovirus-herpes simplex virus glycoprotein B recombinant (Ad-HSV.gB) protects mice against a vaccinia HSV.gB and HSV challenge.
    Endresz V; Berencsi K; Gönczöl E
    Acta Microbiol Immunol Hung; 1995; 42(3):247-54. PubMed ID: 8548197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
    Augustinova H; Hoeller D; Yao F
    J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus.
    Xuan X; Kojima A; Murata T; Mikami T; Otsuka H
    Arch Virol; 1997; 142(5):1003-10. PubMed ID: 9191864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
    Yoshikawa T; Fujii H; Okutani A; Shibamura M; Omura N; Egawa K; Kato H; Inagaki T; Harada S; Yamada S; Morikawa S; Saijo M
    PLoS One; 2018; 13(2):e0192725. PubMed ID: 29474493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.